Efficacy of nivolumab (Nivo) during 2+ line treatment and quality of life in patients with advanced refractory non-small cell lung cancer: Interim results of prospective observational study

Laktionov, K. K., Arzumanyan, A. L., Bolotina, L. V., Breder, V. V., Buevich, N. N., Danilova, A. S., Zinkovskaya, A. V., Kornietskaya, A. L., Kràmchaninov, M. M., Kushniruk, E. K., Latipova, D. H., Moiseenko, F. V., Nikitina, T. P., Okruzshnova, M. A., Orlov, S. V., Orlova, R. V., Porfirèva, N. M., Protsenko, S. A., Sarantseva, K. A., Stroyakovskiy, D. L. & 2 others, Filippova, E. A. & Ionova, T. I., 2019, In: Voprosy Onkologii. 65, 1, p. 99-105 7 p.

Research output: Contribution to journal › Article › peer-review